Your browser doesn't support javascript.
loading
Comprehensive Nonclinical Safety Assessment of Nirmatrelvir Supporting Timely Development of the SARS-COV-2 Antiviral Therapeutic, Paxlovid™.
Sathish, Jean G; Bhatt, Siddhartha; DaSilva, Jamie K; Flynn, Declan; Jenkinson, Stephen; Kalgutkar, Amit S; Liu, Maggie; Manickam, Balasubramanian; Pinkstaff, Jason; Reagan, William J; Shirai, Norimitsu; Shoieb, Ahmed M; Sirivelu, Madhu; Vispute, Saurabh; Vitsky, Allison; Walters, Karen; Wisialowski, Todd A; Updyke, Lawrence W.
Afiliação
  • Sathish JG; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Pearl River, NY, USA.
  • Bhatt S; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.
  • DaSilva JK; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.
  • Flynn D; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.
  • Jenkinson S; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, San Diego, CA, USA.
  • Kalgutkar AS; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Cambridge, MA, USA.
  • Liu M; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, San Diego, CA, USA.
  • Manickam B; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.
  • Pinkstaff J; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, San Diego, CA, USA.
  • Reagan WJ; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.
  • Shirai N; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.
  • Shoieb AM; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.
  • Sirivelu M; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Cambridge, MA, USA.
  • Vispute S; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.
  • Vitsky A; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, San Diego, CA, USA.
  • Walters K; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.
  • Wisialowski TA; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.
  • Updyke LW; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Cambridge, MA, USA.
Int J Toxicol ; 41(4): 276-290, 2022 08.
Article em En | MEDLINE | ID: mdl-35603517

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Tratamento Farmacológico da COVID-19 Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Tratamento Farmacológico da COVID-19 Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article